In today’s academic research environment, speed and precision are everything. Whether you're analyzing trace organic compounds, processing environmental extracts, or running a high-throughput metabolomics project, one bottleneck continues to slow down even the most well-equipped labs: solvent evaporation.If your lab still relies on aging hot plates or hand-drying methods, you’re not alone. But the consequences are real: inconsistent recovery, lost analytes, and valuable hours wasted each week.<h3>The Hidden Cost of Manual Evaporation</h3>Many academic labs were built on traditional sample prep methods. But as research needs evolve and sample volumes increase, these outdated tools can no longer keep up.Manual evaporation doesn’t just slow workflows—it undermines reproducibility.Hot plates can over-dry samples or introduce uneven heating that degrades sensitive compounds. Open evaporation risks contamination. And when multiple students share equipment, timing differences from sample to sample introduce variability that shows up later as noisy chromatography or inconsistent quantitation.Students and faculty alike often report frustration with drying steps taking far too long, especially when preparing dozens of samples for <a target="_blank" rel="noopener noreferrer" href="https://www.organomation.com/preparing-samples-for-lc-ms/ms-analysis?hsLang=en">LC-MS</a> or <a target="_blank" rel="noopener noreferrer" href="https://www.organomation.com/preparing-samples-for-gc-ms/ms-analysis?hsLang=en">GC-MS workflows</a>. In some cases, samples left unattended can be partially lost or require re-preparation entirely.For grant-funded research, that wasted time and material adds up quickly.<h3>A Better Way: Controlled Nitrogen Blowdown</h3>Nitrogen blowdown evaporation replaces guesswork with control. A steady stream of inert nitrogen combined with gentle, regulated heat speeds evaporation while protecting sensitive analytes.<a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products?category=362&amp;manufacturerItems=540">Systems from Organomation </a>are designed specifically for sample preparation—not as improvised solutions or general lab accessories, but as purpose-built tools for consistent concentration.The result is straightforward:<ul style="list-style-type:disc;"><li>Faster dry-downs</li><li>Better recoveries</li><li>Improved reproducibility</li><li>Less hands-on time</li></ul>So researchers can focus on generating data instead of babysitting samples.<h3>Why Academic Labs Choose the N-EVAP</h3>Research labs rarely process identical samples all day.One student may be concentrating a small organic extract, another working with aqueous environmental samples, and a third reducing a larger crude matrix—all at the same time. That variability is exactly where many batch systems fall short.The<a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products?category=362&amp;manufacturerItems=540&amp;search=n-evap"> N-EVAP</a> transforms sample preparation uncertainty into control through radical flexibility.Unlike systems that force you to work around equipment constraints, the N-EVAP’s individual per-sample valves let you adjust gas flow, temperature exposure, and needle positioning for each sample—simultaneously.This isn’t theoretical flexibility. It means you can:<ul><li>Concentrate a 10 mL aqueous sample</li><li>Reduce a 5 mL organic extract</li><li>Evaporate a 50 mL environmental sample</li></ul>—all in the same run, without compromise.<blockquote><a target="_blank" rel="noopener noreferrer" href="https://blog.organomation.com/blog/manual-to-automated-solvent-drying-is-it-worth-the-switch">Learn how the University of Cincinnati achieved 20x faster sample prep with the N-EVAP evaporator.</a></blockquote><ul><li>For academic programs handling variable matrices, this eliminates the false choice between batch efficiency and analytical precision. Each sample gets exactly the conditions it needs, preserving analyte integrity while maintaining throughput. &nbsp;</li><li>Available in configurations from <a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products/2352">6</a> to <a target="_blank" rel="noopener noreferrer" href="https://lcms.labrulez.com/products/1911">45 </a>positions—with optional digital controls on larger models—the system scales easily from small teaching labs to large research groups without forcing workflow changes. &nbsp;</li><li>It’s built for scientists who want control over their experiments, not workarounds. &nbsp;</li><li>Our evaporators are the <a target="_blank" rel="noopener noreferrer" href="https://blog.organomation.com/blog/why-organomation-is-the-most-cited-blowdown-evaporator-brand-in-u.s.-epa-methods">most cited nitrogen blowdown sample concentrators</a> in standardized EPA methods, making Organomation the trusted, fail proof choice.</li></ul><h3>Built for Chromatography Workflows</h3>Since 1959, Organomation has focused exclusively on sample preparation. That specialization shows in the details that matter most to chromatography labs: uniform heating, consistent gas distribution, compatibility with common vial formats, and rugged construction that stands up to daily use in shared academic spaces.Whether you're preparing samples for LC-MS, GC-MS, or other analytical methods, nitrogen blowdown helps ensure:<ul><li>Faster turnaround between experiments</li><li>Consistent recoveries</li><li>Fewer re-runs</li><li>Less student labor tied up in drying steps</li></ul>Which ultimately means more time spent on analysis, interpretation, and publication.<h3>Prove the Time Savings for Yourself</h3>Upgrading your evaporation workflow can clearly improve efficiency—but how much time would your lab actually save? ➔ Rather than guessing, you can calculate it.Organomation’s free <a target="_blank" rel="noopener noreferrer" href="https://explore.organomation.com/evaporation-time-calculator-excel-download">Evaporation Time Savings Calculator</a> lets you enter your real lab conditions—sample counts, volumes, current dry-down times, and run frequency—to quantify exactly how much time nitrogen blowdown could save each week, month, or semester.For many academic labs, the results are eye-opening:<ul><li>Hours of student and staff time reclaimed</li><li>Faster LC-MS/GC-MS queues</li><li>Reduced bottlenecks before analysis</li><li>Hard numbers that help justify equipment purchases in grants and budgets</li></ul>In just a few minutes, you’ll have concrete data showing whether flexible evaporation makes financial and workflow sense for your lab.<blockquote>👉 <a target="_blank" rel="noopener noreferrer" href="https://explore.organomation.com/evaporation-time-calculator-excel-download">Download the Evaporation Time Savings Calculator and see what your lab could save.</a></blockquote>

Is Your University Lab Losing Time and Data in Sample Prep? Here’s How to Fix It

News from LabRulezLCMS Library - Week 17, 2026

🎤Brad Haubrich (Touro University Nevada )Neglected and opportunistic infectious diseases affect some of the world’s most vulnerable populations—but often receive the least attention from traditional drug discovery pipelines.In this episode of Concentrating on Chromatography, host David Oliva sits down with Brad Haubrich to explore how early-stage drug discovery is being applied to fungal and parasitic pathogens, including those responsible for neglected tropical diseases and infections that disproportionately affect immunocompromised patients.Brad shares how his lab approaches drug discovery when the pathogen is eukaryotic—and therefore biologically similar to humans—making selectivity one of the biggest challenges. The conversation covers:<ul><li>What defines neglected and opportunistic diseases—and why commercial incentives often fall short</li><li>Target-based vs. phenotypic drug discovery and when each approach makes sense</li><li>Using binding kinetics and residence time to improve selectivity and reduce off-target effects</li><li>Where chromatography, metabolomics, and mass spectrometry still play a critical role—even when not front-and-center</li><li>The growing (and realistic) role of AI in drug discovery, especially for underfunded disease areas</li><li>Why World Neglected Tropical Diseases Day (January 30) matters for raising awareness and accelerating progress</li></ul>This episode highlights how analytical chemistry, separation science, and biological insight intersect in the earliest stages of drug discovery—and why progress in this space depends as much on collaboration and curiosity as it does on technology.<h3>Video Transcription</h3>In this interview, Dr. Brad Haubrich discusses his research focus on neglected tropical diseases (NTDs) and opportunistic infections. His interest in this field originated during graduate and postdoctoral studies, particularly through work on African sleeping sickness. Neglected diseases are defined as conditions that predominantly affect populations in low- and middle-income countries, where both healthcare infrastructure and commercial incentives for drug development are limited. Similarly, opportunistic infections disproportionately impact immunocompromised individuals, including patients with cancer, transplant recipients, and those undergoing immunosuppressive therapy.A key challenge in this area is the limited commercial interest in drug discovery, resulting in fewer therapeutic options despite significant unmet medical needs. The research emphasizes fungal and parasitic pathogens, which present distinct challenges compared to bacterial targets, particularly due to shared biological pathways between pathogens and human hosts.<h4>Drug Discovery Strategies and Challenges</h4>The discussion highlights two complementary approaches used in the lab: target-based and phenotypic drug discovery. Target-based strategies involve identifying and biochemically characterizing specific pathogen proteins, while phenotypic approaches assess compound activity directly in living cells. Each approach has advantages and limitations, particularly in identifying molecular targets and ensuring biological relevance.A major scientific challenge is achieving selectivity. Because eukaryotic pathogens share many proteins with human cells, identifying compounds that selectively inhibit pathogen targets without affecting host systems is difficult. To address this, the lab incorporates binding kinetics as an early screening parameter. Instead of relying solely on traditional potency metrics, this approach evaluates how long a compound interacts with its target, enabling the identification of molecules with prolonged, selective binding (pseudo-irreversible inhibition), which may improve therapeutic specificity.<h4>Role of Analytical Techniques and Chromatography</h4>Although chromatography is not central to all workflows in the lab, it remains critical in several areas. It is widely used by collaborators for compound purification and plays an important role in emerging projects focused on pharmacognosy, where bioactive compounds are isolated from natural sources such as desert flora.Chromatography, coupled with mass spectrometry, is also essential for metabolomics-based target identification. In phenotypic screening, where the molecular target is initially unknown, changes in metabolite profiles can provide insight into biochemical pathways affected by candidate compounds, supporting target deconvolution.<h4>Impact, Training, and Future Directions</h4>The success of research in neglected diseases is not solely measured by commercial outcomes but also by contributions to scientific knowledge and global health. Even incremental findings can support future therapeutic breakthroughs.The interview also emphasizes the role of students, particularly in academic medical settings, where participation in early-stage drug discovery provides valuable insight into the full pipeline from molecular discovery to clinical application.Looking ahead, artificial intelligence (AI) is identified as a key driver of innovation in drug discovery. AI tools can accelerate compound screening, predict bioactivity, and even suggest synthetic pathways. However, their effectiveness in neglected disease research is currently limited by the availability of large, high-quality datasets.<blockquote>This text has been automatically transcribed from a video presentation using AI technology. It may contain inaccuracies and is not guaranteed to be 100% correct.</blockquote><blockquote><h4>Concentrating on Chromatography Podcast</h4>Dive into the frontiers of chromatography, mass spectrometry, and sample preparation with host David Oliva. Each episode features candid conversations with leading researchers, industry innovators, and passionate scientists who are shaping the future of analytical chemistry. From decoding PFAS detection challenges to exploring the latest in AI-assisted liquid chromatography, this show uncovers practical workflows, sustainability breakthroughs, and the real-world impact of separation science. Whether you’re a chromatographer, lab professional, or researcher you'll discover inspiring content!You can find Concentrating on Chromatography Podcast in podcast apps:<ul><li><a target="_blank" rel="noopener noreferrer" href="https://open.spotify.com/show/1wZg67rCjoGju4yhqxI3tL">Spotify</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://podcasts.apple.com/tz/podcast/concentrating-on-chromatography/id1788429185">Apple podcast</a></li><li><a target="_blank" rel="noopener noreferrer" href="https://podscan.fm/podcasts/concentrating-on-chromatography">podscan</a></li></ul>and on <a target="_blank" rel="noopener noreferrer" href="https://www.youtube.com/@ChromatographyTalk/videos">YouTube channel</a></blockquote>

Drug Discovery Where the Market Doesn’t Go: Targeting Neglected & Opportunistic Pathogens

Article

Product

Application

Video

Scientists

Interview

Science and research

Laboratories

Everything from the world of analytical chemistry in one place. We connect people in solving their problems. At Labrulez you will find all the necessary information easily, quickly and clearly. Stop searching and start finding.

LabRulez

Organomation, founded in 1959, designs and manufactures high-quality nitrogen evaporators and extraction systems. Known for innovation and durability, their lab instruments are used globally for efficient sample preparation with strong customer support.

Organomation

Tosoh Bioscience

Agilent Technologies

Phenomenex

Thermo Fisher Scientific

Shimadzu Corporation

SCIEX

Analytical methods are frequently applied for the characterization of lithium ion batteries. However, additionally they are valuable for the recycling of lithium ion batteries as well. Whether it´s the initial assessment, along the processes or monitoring some of the waste streams. Here, we will present some of the applied techniques and the information, which can obtained.There will also be the opportunity for a live Q&amp;A with the speakers.Learning points:<ul><li>Lithium-ion battery recycling process&nbsp;</li><li>Role of analytical instrumentation in lithium-ion battery recycling&nbsp;</li><li>Guidance on what analytical instruments to employ during the recycling process&nbsp;</li></ul>Who should attend:<ul><li>Researchers in the field of lithium-ion batteries&nbsp;</li><li>Manufacturers of lithium-ion batteries&nbsp;</li><li>Users of analytical instruments in the battery market&nbsp;</li></ul><blockquote>Presenter: Dr. Sascha Nowak (Manager of Division Analytics and Environment, MEET - Münster Electrochemical Energy Technology, University of Münster)Sascha Nowak studied chemistry at the University of Münster and got his PhD in Analytical Chemistry. After his doctorate, he joined the working group of Prof. Winter at the MEET Battery Research Center in 2009 as a postdoctoral researcher where he established the analytical department. From 2010-12 he was the head of the competence areas Analytics and Recycling and since 2012 he holds a position as scientific staff at the MEET Battery Research Center at Münster University as the head of the division Analytics and Environment.Presenter: Simon Goeckler (Market Sales Specialist – Clean Energy Thermo Fisher Scientific)Simon Göckler, Market Sales Specialist for Clean Energy/EMEA at Thermo Fisher Scientific, graduated with a degree in food chemistry in 2005 and earned his PhD in 2009 at KIT. He joined Dionex the same year, gaining extensive experience in ion chromatography and other chromatography techniques. Simon has held various roles in instrument sales and business development. At Thermo Fisher, he focuses on the clean energy market, leveraging his expertise to drive growth and innovation.</blockquote>

Thermo Fisher Scientific: Analytical Possibilities Before, During and After the Recycling of Lithium Ion Batteries

Analytical Possibilities Before, During and After the Recycling of Lithium Ion Batteries

In this webinar you will learn about lithium-ion battery recycling process

Analytical Possibilities of Recycling Li-Ion Batteries

<h4>An introduction to accurate mass and Quadrupole-Time-of-Flight technology with SCIEX</h4>Until recently, nominal mass triple quadrupole technology was considered the gold standard for quantitative assays. In contrast, high-resolution mass spectrometry was primarily used for qualitative, semi-quantitative, and non-targeted workflows, such as metabolite identification, screening, and X-Omics. However, advancements in technology, including faster scan speeds and improved ion optics, have expanded the capabilities of high-resolution spectrometry. Now, it can be effectively applied to both qualitative and quantitative workflows.&nbsp;The ZenoTOF 7600 system, with its high scan rates and enhanced duty cycle at the MS2 level, bridges the gap between these approaches, offering a greater return on investment by reducing data acquisition times and maintaining sensitivity without compromising data quality. This webinar series will focus on how to transition from the Triple Quad to a high-resolution environment for different applications.This webinar series will contain 3 parts. Each part will be 20 minutes with a 10 minute Q&amp;A.<h4>Part 2: Advantages of HRMS for Quantitative Workflows</h4><ul><li>Efficiency and Cost Savings: Discover how HRMS quantitation can significantly reduce time and expenses</li><li>Seamless Transition: Learn the steps to transition your established MRM assays to MRMHR with ease</li><li>Streamlined Processes: Explore methods to streamline the entire workflow from biomarker discovery to quantitation&nbsp;</li></ul><blockquote>Presenter: Heather Chassaing (Senior Accurate Mass Workflow Specialist, SCIEX)Heather Chassaing has over 20 years of experience in analytical science, with a strong background in biochemistry. She has worked extensively in both the agrochemical and pharmaceutical industries, gaining comprehensive expertise in the research and development of drug entities, as well as the complexities of drug production. Heather is particularly passionate about structural elucidation and the application of Mass Spectrometry to these workflows.</blockquote>

SCIEX: An introduction to accurate mass and Quadrupole-Time-of-Flight technology with SCIEX

Advantages of HRMS for Quantitative Workflows

Discover how HRMS quantitation can significantly reduce time and expenses and how to transition your established MRM assays to MRMHR with ease.

The recent rise in export rejections due to contamination from mineral oil saturated hydrocarbons (MOSH) and mineral oil aromatic hydrocarbons (MOAH) has become a pressing concern for the food industry. Known for their links to health risks such as organ toxicity, carcinogenicity, and tissue accumulation, MOSH/ MOAH contamination underscores the urgent need to safeguard public health and comply with evolving regulations.Shimadzu, in collaboration with Axel Semrau, introduces an enhanced turnkey analytical solution to enable effective MOSH/MOAH analysis. Join our latest session in Digital Classrooms to gain exclusive insights into the new and improved MOSH/MOAH detection method, strategies for navigating regulatory compliance, and actionable solutions to mitigate contamination risks effectively.Tailored for regulators, private testing laboratories, and food manufacturers, this session is a must-attend to enhance your expertise to do food testing with compliance.Equip yourself with Shimadzu's solutions to address one of the food industry’s most significant challenges. Register now!<h5>Learning Objectives</h5><ul><li>Discover the latest trends and challenges surrounding MOSH/ MOAH contamination in the food industry.</li><li>Explore cutting-edge advancements in MOSH and MOAH analyzers, paving the way for more accurate and efficient detection.</li><li>Learn how Shimadzu’s innovative solutions can effectively manage contamination risks and ensure compliance with evolving regulations.</li></ul><blockquote>Presenter: Goh Wan Yu Elton (Market Specialist - Food And Environmental, Shimadzu (Asia Pacific) Pte Ltd)Elton dedicates his career to food analytics, ensuring the safety and quality of our daily consumption. As a Food Specialist at Shimadzu, he develops and applies advanced analytical techniques to detect and quantify compounds in food products, from contaminants to nutrients. Elton takes pride in advancing food science, enhancing safety, and building consumer trust. His goal is to make valuable contributions to analytical chemistry and the global food industry.</blockquote>

Shimadzu: Enhancing Food Testing: New And Improved Method For MOSH/MOAH Contamination

Enhancing Food Testing: New And Improved Method For MOSH/MOAH Contamination

Learn about MOSH/MOAH detection, regulatory tips, and solutions to reduce contamination risks in our latest Digital Classrooms session.

Food Testing: Method For MOSH/MOAH Contamination

<h4>Overview</h4>This webinar, co-hosted by Phenomenex and the Bio-Analytical Separation Science Group at Vrije Universiteit Brussel, will cover:<ul><li>The growing potential of oligonucleotide therapeutics and the importance of thorough impurity profiling.</li><li>Challenges in detecting critical impurities such as shortmers and phosphodiesters (PO) during synthesis.</li><li>Ion-pair reversed-phase liquid chromatography’s (IP-RPLC) mechanism of action for high-resolution impurity analysis.</li><li>Evaluating the impact of column preheaters on analyte dispersion and method performance.</li><li>The role of fluoroalcohols in enhancing LC separation and MS detection.</li><li>Comparing bio-inert columns for improved impurity profiling outcomes.</li></ul><h4>Key Learning Points</h4><ul><li>Understand the therapeutic mechanisms of oligonucleotides and the significance of base, ribose, and phosphate modifications.</li><li>Recognize the analytical challenges in oligonucleotide impurity profiling, including shortmers and phosphodiester impurities.</li><li>Learn how to develop and optimize IP-RPLC-MS methods for high-throughput analysis.</li><li>Evaluate the influence of preheater effects and fluoroalcohols on separation and detection sensitivity.</li><li>Compare the performance of bio-inert columns for impurity profiling.</li></ul><h4>Who Should Attend</h4><ul><li>Oligonucleotide Researchers: Ideal for scientists involved in developing and characterizing oligonucleotide therapeutics.</li><li>Analytical Chemists: Professionals focused on impurity profiling and method optimization using advanced chromatographic techniques.</li><li>Biopharmaceutical Quality Control Experts: Valuable for those ensuring the purity, stability, and safety of oligonucleotide-based therapeutics.</li><li>Contract Research Organizations</li><li>Biopharmaceutical Innovator Companies</li></ul><blockquote>Speaker: Dr. Sebastiaan Eeltink &nbsp;(Professor and lead investigator of the Eeltink Laboratory at the University of Brussel &amp; Editor of Analytical Science Advances at Wiley)Dr. Sebastiaan Eeltink is a Full Professor and lead investigator of the Eeltink Laboratory at the University of Brussel and an Editor of Analytical Science Advances at Wiley. His team focuses on developing and designing novel analytics for the high-resolution profiling of biomolecules and biomolecular interactions using ultrahigh-pressure liquid chromatography (UHPLC) and multi-dimensional liquid chromatographic workflows with mass spectrometry (MS) detection. In addition, his team also manages the University’s proteomics platform which offers high-performance LC-MS proteomics profiling expertise and advise to academic and industrial collaborators.Speaker: Quang-Dong Bui &nbsp;(PhD student at University of Brussels)Quang-Dong Bui is currently a PhD student at University of Brussels under the supervision of Professor Sebastiaan Eeltink, where he develops analytical methods for key oligonucleotide projects and is an active scientist in the oligonucleotide and mRNA research community.</blockquote>

Phenomenex: Advanced IP-RPLC-MS Strategies for High-Resolution Oligonucleotide Impurity Profiling

Advanced IP-RPLC-MS Strategies for High-Resolution Oligonucleotide Impurity Profiling

Discover advanced IP-RPLC-MS methods for high-resolution oligonucleotide impurity analysis. Enhance your analytical workflows and data precision.​

Advanced IP-RPLC-MS for Oligonucleotide Profiling

Synthetic peptides have emerged as a significant class of therapeutic agents, particularly in the management of metabolic disorders such as type 2 diabetes mellitus. Among these, glucagon-like peptide-1 (GLP-1) receptor agonists have gained prominence due to their multifaceted role in glucose regulation and weight management. Over the past decade, we have witnessed a rise in approvals for these molecules, and the generics market is gearing up as some of these drugs approach patent expiration.Due to the diverse amino acid sequences and structural complexities, synthetic peptides require robust and precise analytical methods to ensure their quality, efficacy, and safety. However, the lack of harmonized regulatory guidelines for peptide characterization presents significant challenges. Certain critical quality attributes (CQAs) are widely accepted among the peptide community, necessitating sophisticated analytical techniques.Given the ongoing speculation in the market regarding the best analytical techniques for synthetic peptides, we are hosting this event to provide a platform for analytical users and chemists working with peptides to ask their queries directly to experts like yourself.Don’t let workflow challenges slow you down. Join us to unlock the full potential of your workflows, enhance your technical skills, and take a significant step in your professional development.<blockquote>Presenter: Dr. Vasanthakumar G. Ramu (Vice President – Head R&amp;D, Peptides and Complex API’s, Alembic Pharmaceutical Ltd.)Dr. Vasanthakumar Ramu, is one of the pragmatic scientists in the pharma industry working around complex API’s. He studied chemical biology from Bangalore University and Indian Institute of Science. In early 2007, hemoved to Max-Planck Institute of Molecular Physiology to work on peptide decorated supramolecular architectures as modulators to study cell protein interactions. Continued further studies as research scientist in Ruhr Universität Bochum, Germany, with the objective to work on backbone modified peptides of HIV protease inhibitors. In 2011 spring, moved to Spain, where he was working as Marie Curie Experienced Researcher to develop Kyotorphin derived peptides, antimicrobial peptides, and other small molecules for neurodegeneration. Returned to India in 2012 and led the startup company called Omgene Life Sciences Pvt. Ltd. Before joining Alembic, was heading peptide process development groups in Biocon Ltd., and Aurobindo Pharma Ltd., Transferred the technologies, successfully validated and filed various DMF’s and involved in commercialization of API’s.Presenter: Dr. Rakesh Shekhawat (Founder/Owner, Proantek Research Labs Pvt. Ltd)Dr. Rakesh Shekhawat is a distinguished scientist with over 20 years of industrial research experience in the fields of synthetic peptides, biosimilars, and oligonucleotide characterization. Holding a Ph.D. in analytical chemistry, Dr. Shekhawat has led analytical research teams at prominent companies such as Intas and USV, contributed significantly to securing various regulatory approvals for biosimilars and synthetic peptides. Recently, he founded Proantek Research Labs Pvt. Ltd., a company dedicated to the advanced characterization of biosimilars, synthetic peptides, and oligonucleotides.Presenter: Dr. Vadi Bhat (Sales Development Manager - Biopharma, Agilent Technologies)Vadi Bhat, Ph.D., is a seasoned biopharma business development manager at Agilent Technologies in India, bringing extensive expertise in biopharmaceutical research and development. He holds a Ph.D. in chemical biology from JNCASR/IISc and completed postdoctoral research at MIT. Dr. Bhat's career includes experience in mass spectrometry core facility management at Baylor Scott &amp; White Hospital/Texas A&amp;M University.Since joining Agilent in 2008, he has played a key role in developing innovative LC-MS workflows for proteomics and biopharma applications, initially at Agilent's Little Falls Center of Excellence in Delaware. From 2015 to 2017, he served as a proteomics market specialist within Agilent's North America Field Team, driving customer collaborations and business development. Transitioning to his current role in India in 2017, he focuses on fostering collaborations and driving business growth in the biopharma sector. Dr. Bhat's contributions to the field are reflected in numerous peer-reviewed publications and presentations at scientific conferences. In 2023, he was appointed adjunct professor at the Manipal Centre for Biotherapeutics Research (MCBR), MAHE, further demonstrating his dedication to advancing biopharma research.Presenter: Dr. Ashish Pargaonkar (Biopharma Workflow Commercialization Lead, Agilent Technologies)Dr. Ashish Pargaonkar is a Lead for Biopharma Workflow Commercialization team for India and also Manager for Centre of Excellences at Bangalore. A Microbiologist by education with a Ph.D, he holds more than 20 years of experience for Biopharma market applications on Hi Resolution Mass Spectrometry. He has a long record of successful demonstrations and customer engagements on workflows for CQA’s, Intact mass, peptide mapping, HCP and Glycans using Agilent state-of-the art solutions. He has authored ASMS posters on media components and therapeutic peptides. Dr. Ashish has been invited speaker at several conferences and workshops at Biosimilar Congress, ADC 2018, IIT (Mumbai, Delhi), ICT (Mumbai), PSI events.Presenter: Dr. Sunil B Lakhmapure (Technical Support Specialist, Agilent Technologies India Pvt. Ltd.)Sunil holds 19 year plus experience in the analytical field with major exposure to LC/GC with Single Quad, Triple Quad and high resolution (QToF) mass spectroscopy. Started career in Pharma R&amp;D as a scientist with hands on experience on high end instruments like LC/MS, XRD &amp; NMR. Developed &amp; published application notes using Chromatographic techniques on real world samples/issues at various levels.</blockquote>

Agilent Technologies: Ask The Expert - Peptide Workflow

Ask The Expert - Peptide Workflow

Join us to unlock full potential of your workflows, enhance your technical skills

<div><div container-id="cq-colctrl-lt0" comp-id="A1"><div>When looking for new ways to increase sample throughput in proteomics, without compromising on proteome profiling or quantitation, Thermo Scientific Vanquish Neo UHPLC systems and Thermo Scientific µPAC Neo columns can really make a difference.Using the Vanquish Neo system, with its newly introduced tandem workflow, a dual separation workflow in a single system is created to maximize MS utilization for high-throughput and deep-dive proteomics.Benefiting from the perfectly ordered microfabrication of the Thermo Scientific™ µPAC™ Neo columns, this workflow has advanced proteomics research into the next era with maximal reproducibility and robustness.Join this free webinar to learn more about how you can employ Vanquish Neo Tandem Workflow systems and µPAC Neo columns in your lab.In this webinar, we present to you how to meet increasing sample queue demands without compromising separation and MS results by:<ul><li>using the Vanquish Neo UHPLC system for low-flow separations in proteomics</li><li>maximizing mass spectrometer utilization with the Vanquish Neo Tandem Direct-Injection workflow for increased sample throughput, and minimized column carryover</li><li>Tandem Direct-Injection workflow for nano, capillary and micro-flow applications</li><li>utilizing the unique micro-pillar array backbone to provide both, highest robustness and consistency</li></ul>Cannot join on May 20? Please register anyway to automatically receive the link to the recording.<blockquote>Presenter: Robert van Ling (Product Manager Low-flow HPLC Columns, Thermo Fisher Scientific)Experienced marketeer &amp; business developer, as well as technical sales support specialist, for the biopharma and omics community. 25+ years of protein, peptide and RNA chromatography and LC/MS experience, focused on providing researchers with innovative and high-performance workflows and solutions.</blockquote></div></div></div>

Thermo Fisher Scientific: Innovative separation approaches for MS-based proteomics

Innovative separation approaches for MS-based proteomics

Join this free webinar to learn more about how you can employ Vanquish Neo Tandem Workflow systems and µPAC Neo columns in your lab.

<div><div container-id="cq-colctrl-lt0" comp-id="A1"><div>Join us for a webinar on the critical importance of keeping your Chromatography Data System (CDS) up to date to ensure ongoing compliance, performance, and security. Whether you are using Chromeleon software or considering a switch from another CDS, this session will provide valuable insights into the benefits of having validated software running on supported operating systems and databases. Our experienced Professional Services team will support you throughout the migration, handling the heavy lifting and guiding you toward a successful project outcome.<h4>Key learning points</h4><ul><li>Understand why regular updates matter</li><li>How to plan a smooth software transition</li><li>How to manage enterprise-wide migrations effectively</li><li>Explore how Thermo Fisher can help you meet audit requirements and reduce project timelines with our computerized system validation services</li></ul><h4>Who should attend?</h4><ul><li>Lab scientists and technicians working on quantitative analysis</li></ul><blockquote>Presenter: Kimy Young (Senior Manager, Software Product Specialists, Thermo Fisher Scientific)Kimy Young is the Senior Manager of software product specialists at Thermo Fisher Scientific. She has been with Thermo Fisher since November 2015. Her background includes administration of Chromeleon CDS, laboratory information management systems (LIMS), Quality Assurance (QA), and IT projects.Presenter:&nbsp;Joe Ault (Senior Product Marketing Manager, Thermo Fisher Scientific)Joe Ault has a diverse pharma background, contributing to validation campaigns for both gene therapy startups and large firms. As a former senior manager of computerized system validation, he focused on commercialization. Joe has also been a validation consultant for chromatography data systems, ensuring compliance. He now delivers validation services for Thermo Fisher Scientific's enterprise software products.</blockquote></div></div></div>

Thermo Fisher Scientific: Optimizing compliance & performance: CDS update and migration strategies

Optimizing compliance & performance: CDS update and migration strategies

Webinar on the critical importance of keeping your Chromatography Data System (CDS) up to date

CDS update and migration strategies

<div><div container-id="cq-colctrl-lt0" comp-id="A1"><div>Join us for an exclusive opportunity to connect directly with Thermo ScientificTM ChromeleonTM Chromatography Data System (CDS) product experts in this interactive webinar session focused specifically on data processing and data reporting. This interactive session brings together specialists from our product marketing and product management teams to address your Chromeleon challenges and help you maximize the platform's capabilities.The heart of this webinar is live software demonstrations, where our experts will show you exactly how to implement solutions within Chromeleon CDS. Watch as they navigate the software in real-time, revealing practical techniques to enhance your laboratory workflows.This session will be driven by you — our users! &nbsp;Bring your questions about:<ul><li>Data processing strategies and best practices</li><li>Custom report creation and template design</li><li>Statistical analysis tools and calculations</li><li>Data visualization techniques</li></ul>Submit your questions early! Questions submitted prior to 7 May will be prioritized, giving you the best chance to have your specific challenges addressed during the webinar.Whether you're looking to solve specific challenges or simply enhance your Chromeleon expertise, this interactive Q&amp;A session will provide valuable insights directly applicable to your daily work.<blockquote>Presenter: Barbara van Cann (Senior Manager, Product Management, Thermo Fisher Scientific)Barbara van Cann holds a Bachelor of Science in Analytical Chemistry and has accumulated over 25 years of experience at Thermo Fisher Scientific (Dionex). Her extensive background encompasses analytical chemistry, chromatography hardware, and computer software.Throughout her career, Barbara has held various roles within the Dutch sales organization, including IC Application Chemist and Sales Support for HPLC and Chromeleon software. She later transitioned to the Chromeleon team, where she currently serves as the Senior Manager for Product Management within the CMD Software organization. In this capacity, Barbara is responsible for identifying customer requirements for Chromeleon CDS, driving roadmap planning, and developing product strategies to maximize customer value and impact.Presenter:&nbsp;Peter Sauter (Product Manager, Thermo Fisher Scientific)Graduated in 1986 with a Diploma in Mathematics at the University in Ulm / Germany.Joined Softron in 1986 which later became Gynkotek/Softron and Dionex/Softron (now as part of Thermo Fisher Scientific) and worked over the past almost 40 years as a developer, R&amp;D manager and nowadays as product manager in the development of various chromatography data systems and customer specific Addons such as Kontron Datasystem 420, &nbsp;GynkoSoft, Chromeleon 6 and Chromeleon 7. &nbsp;Presenter:&nbsp;Anthony Crawshaw (Product Manager, Thermo Fisher Scientific)Graduated in 1997 with an BSc in Applied Chemistry from Sheffield Hallam University. &nbsp;Subsequently worked in Pharmaceutical Contract Research Organisations (Aptuit and Almac). &nbsp;This varied from Pharmaceutical Analysis labs, through to method development and validation. &nbsp; Joined Dionex (later to become Thermo Fisher Scientific) in 2011 as a Sales Support Specialist, supporting the UK sales teams with both HPLC Hardware and applications, as well as Chromeleon and Chromeleon Enterprise support. &nbsp;This involved the management and deployment of the Chromeleon Enterprise systems within the UK at customer sites. &nbsp;In 2018, transitioned to the newly formed Global eCDS team, supporting EMEA. &nbsp;This solely focused on Chromeleon and Chromeleon Enterprise deployments. &nbsp;In 2022, transitioned into Product Management as the PM for Chromeleon Enterprise.Presenter:&nbsp;Darren Barrington-Light (Senior Manager, Product Marketing, Thermo Fisher Scientific)Darren has worked for over 30 years with Chromatography Data Systems and for over 25 years with Chromeleon CDS. He has a unique understanding of the requirements of organizations that rely on data to manage their day to day operations. &nbsp;As capabilities have advanced, Darren has worked with clients across multiple industries to show them how enterprise-level software can help them to improve their day to day operations and drive fast, informed decisions.Presenter:&nbsp;Zoe Julian (Product Marketing Manager, Chromatography Software, Thermo Fisher Scientific)With over 12 years of experience working with chromatography and mass spectrometry techniques with a background in GC and GC-MS(/MS) organic environmental analysis, Zoe Julian has helped many laboratories and industries improve workflows through a unique understanding of their challenges. Transitioning to a focus on Thermo Scientific Chromeleon CDS, she has shown customers how software solutions can improve their productivity and support their day-to-day operations.Presenter:&nbsp;Laércio Fernandes (Product Marketing Manager, Chromatography Software, Thermo Fisher Scientific)With a background rooted in analytical chemistry, sales, and support, Laércio Fernandes has over 15 years of experience in the analytical field and has worked in constant connection with Thermo Scientific Chromeleon CDS and chromatography instrumentation with a focus on ion chromatography, IT, and Cloud. His background in sales and support has enabled his good overview and understanding of different processes and challenges that laboratories may face. This has allowed him to better support customers to improve their workflows and productivity.&nbsp;</blockquote></div></div></div>

Thermo Fisher Scientific: Let’s Talk Chromeleon: Interactive Q&A with Product Experts

Let’s Talk Chromeleon: Interactive Q&A with Product Experts

Exclusive opportunity to connect directly with Thermo Scientific Chromeleon Chromatography Data System product experts in interactive webinar session.

Anson Lewis, Global Sales Manager at Tosoh Bioscience, will present the next edition of Tosoh Tuesday, a webinar series held by Chromatography Experts.On Tuesday, May 20, Benjamin R. McDonald, Assistant Professor at Brown University, will discuss the preparation and characterization of ultra dense bottle brush polymers (BBPs), specifically focusing on the critical role that Multi-Angle Light Scattering (MALS) and Small Angle X-ray Scattering (SAXS) play in validating the molecular structure and elucidating fundamental structure-activity relationships with between grafting density, rigidity, CLC behavior.Note, this event is a single presentation being offered at 2 times for your scheduling convenience.After the webinar, ask your questions during the Q&amp;A session.<blockquote>Presenter: Anson Lewis (Global Sales Manager at Tosoh Bioscience)Presenter: Benjamin R. McDonald (Assistant Professor at Brown University)Presenter:&nbsp;Tianyu Li</blockquote>

Tosoh Bioscience: Tosoh Tuesday - Synthesis and Characterization of Bottle Brush Polymers

Tosoh Tuesday - Synthesis and Characterization of Bottle Brush Polymers

Explore how MALS and SAXS techniques reveal key structure–activity insights in ultra-dense bottle brush polymers.

Synthesis and Characterization of Bottle Brush Polymers

In this webinar we will explore the Merel, dissoBOT system, a pioneering technology in the pharmaceutical testing landscape, introducing the first fully automated dissolution system featuring clip-on/off capabilities.This state-of-the-art system simplifies the dissolution process by enabling automatic sequential operations—cleaning, media dispensing, and sample introduction without interfering with the ongoing dissolution process. Designed to work seamlessly with established systems such as the Agilent 850-DS Dissolution Sampling Station and the 708-DS Dissolution Apparatus, dissoBOT enhances efficiency and reproducibility. The advanced automation facilitated by collaborative robotics allows for extended operational cycles and minimal setup time, with a clip-on procedure completing in less than a minute.This webinar will detail the operational principles, components like the Dosage Delivery Module (DDM), and the integration capabilities of the dissoBOT with current dissolution apparatuses, ensuring precise media dispensing and accurate sample analysis. Participants of this webinar will gain in-depth knowledge and practical insights into the automation of the dissolution testing process using the Merel dissoBOT system.<h5>Key learning objectives include:</h5><ul><li>Understanding the foundational technology behind the dissoBOT's clip-on/off capability and its integration with existing dissolution systems.</li><li>Exploring the automated functions of the dissoBOT, including sequential media dispensing, cleaning, and sample introduction, and how these operations enhance testing efficiency and accuracy.</li><li>Learning about the compatibility of the dissoBOT with common dissolution apparatuses like the Agilent 708-DS and the 850-DS Dissolution Sampling Station.</li><li>Gaining insights into the process enhancements brought by the dissoBOT, such as reduced manual intervention, increased reproducibility, and streamlined workflow.</li><li>Discovering the technical specifics of the system components, including the Dosage Delivery Module, dissoDOSE technology, and automated sample collection methods.</li><li>Understanding the impact of dissoBOT on pharmaceutical quality control and how it can lead to more reliable and faster dissolution testing results.</li></ul><blockquote>Presenter: Owain McKenzie (Dissolution Business Team Manager EMEA, Agilent Technologies)Owain McKenzie is currently the EMEA Dissolution Business Team Manager with Agilent. Since 2000 Owain has performed analytical testing, supervised pharmaceutical laboratories, run sales teams, and managed customer support teams with GSK, VanKel, Erweka, Varian and Agilent. Primary responsibilities have been in the fields of product release, stability, product development and support, LC, MS &amp; UV. Dissolution method development and validation, instrument qualification and calibration, technology transfers and training. Current activities since 2010 have focused on providing method and technical application support for dissolution and drug release testing in the pharmaceutical industry as well as Agilent R&amp;D, Marketing and Sales teams. Owain provides numerous talks and publications on dissolution related techniques and topics including publication of the Immediate Release Newsletter, and Dissolution Discussion Group (DDG). He received his MSc degree in Chemistry from the University of Leeds, UK, and is an active member of both the Royal Pharmaceutical Society and the Royal Society of Chemistry in London UK.Presenter: Nejc Zorko Horvat (Product Manager, Merel)Nejc Zorko Horvat has been working in the field of dissolution, UV-Vis-NIR, and fluorescence spectroscopy for 15 years. He manages domestic and international projects, including installation, qualification, and customer training on novel and complex systems. With extensive experience supporting customers in GMP environments and numerous compliance trainings, his main focus is on the pharmaceutical market.His background in IT allows him to provide solutions for both hardware and local or networked software. Since 2024, he has been managing the complete portfolio of Merel Instruments in foreign markets. His role includes presenting at international seminars, fairs, and specialized events, conducting online product demos, managing dealers, and visiting customers.</blockquote>

Agilent Technologies: Automation Of Dissolution Process With The Merel dissoBOT System

Automation Of Dissolution Process With The Merel dissoBOT System

In this webinar we will explore the Merel, dissoBOT system, a pioneering technology in the pharmaceutical testing landscape

Related content

Drug Discovery Where the Market Doesn’t Go: Targeting Neglected & Opportunistic Pathogens

Is Your University Lab Losing Time and Data in Sample Prep? Here’s How to Fix It

News from LabRulezLCMS Library - Week 17, 2026